| Uric Acid & Cancer | Sabri BARUTÇA, Hatice YILMAZ | 141–146 |
| Impact of Breast Cancer Subtypes on Pathological Complete Response Following Neoadjuvant Chemotherapy | Melike ÖZÇELİK, İbrahim ÇİL, Abdilkerim OYMAN | 147–150 |
| COVID-19 Pandemic is More Dangerous Than We Think | Mustafa Murat MIDIK, Denis ÇETİN, Ulus Ali ŞANLU, Burcak KARACA, Erdem GÖKER, Elvina ALMURADOVA | 151–156 |
| General Anesthesia versus Sedation in Multi Parametric Magnetic Resonance Imaging (mpMRI) Transrectal Ultrasound Guided (TRUS) Fusion Targeted Prostate Biopsy: A Prospective, Randomized Study | Suna KOÇ, Harun UYSAL | 157–164 |
| Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer | Osman KÖSTEK, Evrim ABAMOR, Sermin ÇOBAN KÖKTEN, Hatice ODABAŞ, Mahmut Emre YILDIRIM, Aysun KÜÇÜKÖZ UZUN, Murat AYHAN, Nedim TURAN, Deniz TATAROĞLU ÖZYÜKSELER | 165–175 |
| Survival Analysis of Our Patients Diagnosed with Testicular Cancer | Mustafa YILDIRIM, Özlem Nuray SEVER, Serkan ENKİ, Mustafa YILDIZ, Tahir YERLİKAYA, Mehmet SOLAKHAN | 176–179 |
| The Clinical Effect of Triglyceride Glucose index, aninsulin Resistance Marker, on Predicting Paclitaxel-induced Neuropathy | Utku Donem GONDOĞDU, Funda KARABAĞ ÇOBAN | 180–183 |
| In Which Luminal Breast Cancers Might Neoadjuvant Chemotherapy Be Appropriate to Achieve a Pathological Complete Response in Axillary Lymph Nodes? | Eda TANRIKULU ŞİMŞEK, Elif ATAĞ, Ezgi ÇOBAN, Murat SARI, Gunay GÜRLEYİK | 184–189 |
| Could ARNI have an Effect on LV Fibrosis and Inflammatory Parameters in an Experimental Autoimmune Myocarditis Model? | Rahime ÖZLEM ÖZTOPUZ, Bulent DEVECİ, Ali DUYGU, Yasemen ADALI, Emine GAZİ, Mehmet ARSLAN | 190–197 |
| Long-Term Effects of COVID-19 Pandemic on Oncology Patients | Ismail BEYPINAR, Muslih ÜRÜN | 198–202 |
| Prognostic Factors in Advanced Pancreatic Cancer: Single-Center, Real-World Data | Eda TANRIKULU ŞİMŞEK | 203–209 |
|